October 21, 2014 11:29 AM ET

Biotechnology

Company Overview of Mirna Therapeutics, Inc.

Company Overview

Mirna Therapeutics, Inc., a biopharmaceutical company, is engaged in the development and commercialization of microRNA (miRNA) therapeutics. The company focuses on miRNA-directed oncology therapies. It offers MRX34, a series of clinical therapeutic candidates to mimic the activity of a human miRNA. Its product candidates target cancers, such as solid and blood-borne tumors with a focus on hepatocellular carcinoma, non-small cell lung cancer, colorectal cancer, and pancreatic carcinoma. The company was founded in 2007 and is based in Austin, Texas. Mirna Therapeutics, Inc. operates as a subsidiary of Asuragen, Inc.

2150 Woodward Street

Suite 100

Austin, TX 78744

United States

Founded in 2007

Phone:

512-901-0900

Fax:

512-681-5201

Key Executives for Mirna Therapeutics, Inc.

Chief Executive Officer
Age: 56
Chief Financial Officer and Secretary
Age: 54
Senior Vice President and General Counsel
Chief Medical Officer and Vice President of Oncology
Compensation as of Fiscal Year 2014.

Mirna Therapeutics, Inc. Key Developments

Mirna Therapeutics, Inc. Appoints Lawrence M. Alleva to its Board of Directors

Mirna Therapeutics announced the appointment of Lawrence M. Alleva, a former partner with PricewaterhouseCoopers LLP, as an outside director to its Board of Directors. Prior to his retirement in 2010, Mr. Alleva was with PricewaterhouseCoopers LLP (PwC) for 39 years, 28 of which as a partner with the firm.

Mirna Therapeutics, Inc. Presents at 13th Annual BIO Investor Forum, Oct-08-2014 11:30 AM

Mirna Therapeutics, Inc. Presents at 13th Annual BIO Investor Forum, Oct-08-2014 11:30 AM. Venue: The Palace Hotel, San Francisco, CA 94105, United States.

Mirna Therapeutics, Inc. Presents at 14th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-30-2014 02:45 PM

Mirna Therapeutics, Inc. Presents at 14th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-30-2014 02:45 PM. Venue: Congress Center Basel, MCH Messe Schweiz (Basel) AG, CH-4005 Basel, Switzerland. Speakers: Casi DeYoung, Chief Business Officer.

Similar Private Companies By Industry

Company Name Region
Hanson Technologies, Inc. United States
MatTek Corporation United States
Antrim Corporation United States
Audeo Oncology, Inc. United States
Matrix Genetics United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Mirna Therapeutics, Inc., please visit www.mirnatherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.